Arrazzi Room FRIDAY, OCTOBER 16, 2015

Back to PDF Presentations


08.30 – 10.15

Amiodarone in patients with LV dysfunction: how safe is it?
G.L. Botto / Como, Italy

Ranalozine as a promising treatment option for AF, alone or in combination with
other AADs

A.J. Camm / London, UK


10.45 – 12.30

Increased mortality with dronedarone: is digoxin the cause?
A. Capucci/ Ancona, Italy

Dronedarone in the real world: how safe is it?
L. Friberg / Stockholm, Sweden

AF in patients with CAD: is dronedarone a good choice?
H.J.G.M. Crijns / Maastricht, The Netherlands

Dronedarone: which patient is most likely to benefit from it?
H.J.G.M. Crijns / Maastricht, The Netherlands


12.30 – 14.00

NOACs : pharmacological differences
A. Corsini / Milan, Italy

The clinical relevance of AMPLIFY programme
F. Dentali / Varese, Italy

Stroke prevention in non valvular atrial fibrillation: efficacy vs safety
G.L. Botto / Como, Italy

Challenging practical situations
A. Squizzato / Varese, Italy


14.00 – 15.45

After trans-catheter ablation
S. Themistoclakis / Venice-Mestre, Italy


16.15 – 17.25

New insight from ENGAGE
R.P. Giugliano/ Boston, USA

Real-life data from PREFER in AF Registry
R. De Caterina / Chieti, Italy


17.25 – 18.00

Have we changed the face of anticoagulation?
Speaker
S.J. Connolly/ Hamilton, Canada


18.00 – 19.30

Distinguished Scientist Golden Lionel Award

Lecture: History never looks like history when you are living through it
Sami Viskin


Distinguished Teacher Golden Lionel Award

Lecture: The Continuing Challenge of Catheter Ablation for Ventricular Tachycardia
Willian G. Stevenson